Literature DB >> 7753621

Cloning, sequencing and bacterial expression of human glycine tRNA synthetase.

J Williams1, S Osvath, T F Khong, M Pearse, D Power.   

Abstract

The human glycine tRNA synthetase gene (GlyRS) has been cloned and sequenced. The 2462 bp cDNA for this gene contains a large open reading frame (ORF) encoding 685 amino acids with predicted M(r) = 77,507 Da. The protein sequence has approximately 60% identity with B. mori GlyRS and 45% identity with S. cerevisiae GlyRS and contains motifs 2 and 3 characteristic of Class II tRNA synthetases. A second ORF encoding 47 amino acids is found upstream of the large ORF. Translation of this ORF may precede the expression of GlyRS as a possible regulatory mechanism. The enzyme was expressed in E. coli as a fusion protein with a 13 kDa biotinylated tag with an apparent M(r) = 90 kDa. The fusion protein was immunoprecipitated from crude bacterial extract with human EJ serum, which contains autoantibodies directed against GlyRS, and with rabbit polyclonal serum raised against a synthetic peptide derived from the predicted amino acid sequence of human GlyRS. Bacterial extract containing the fusion protein catalyses the aminoacylation of bovine tRNA with [14C]-gly at 10-fold increased level above normal bacterial extract and confirms that the cDNA encodes human GlyRS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753621      PMCID: PMC306854          DOI: 10.1093/nar/23.8.1307

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  11 in total

1.  CLUSTAL V: improved software for multiple sequence alignment.

Authors:  D G Higgins; A J Bleasby; R Fuchs
Journal:  Comput Appl Biosci       Date:  1992-04

2.  Binding of human glutaminyl-tRNA synthetase to a specific site of its mRNA.

Authors:  B Schray; R Knippers
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

3.  Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis.

Authors:  I N Targoff
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

Review 4.  Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs.

Authors:  P Schimmel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Glycyl- and alanyl-tRNA synthetases from Bombyx mori. Purification and properties.

Authors:  S S Dignam; J D Dignam
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

6.  Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs.

Authors:  G Eriani; M Delarue; O Poch; J Gangloff; D Moras
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

7.  Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease.

Authors:  M Hirakata; T Mimori; M Akizuki; J Craft; J A Hardin; M Homma
Journal:  Arthritis Rheum       Date:  1992-04

8.  Primary structure of the gene for glycyl-tRNA synthetase from Bombyx mori.

Authors:  S Nada; P K Chang; J D Dignam
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

9.  Post-transcriptional regulation of glutamyl-prolyl-tRNA synthetase in rat salivary gland.

Authors:  S M Ting; J D Dignam
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  5 in total

1.  Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.

Authors:  Anthony Antonellis; Shih-Queen Lee-Lin; Amy Wasterlain; Paul Leo; Martha Quezado; Lev G Goldfarb; Kyungjae Myung; Shawn Burgess; Kenneth H Fischbeck; Eric D Green
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

2.  Elaborate uORF/IRES features control expression and localization of human glycyl-tRNA synthetase.

Authors:  Jana Alexandrova; Caroline Paulus; Joëlle Rudinger-Thirion; Fabrice Jossinet; Magali Frugier
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.

Authors:  Francesca Achilli; Virginie Bros-Facer; Hazel P Williams; Gareth T Banks; Mona AlQatari; Ruth Chia; Valter Tucci; Michael Groves; Carole D Nickols; Kevin L Seburn; Rachel Kendall; Muhammed Z Cader; Kevin Talbot; Jan van Minnen; Robert W Burgess; Sebastian Brandner; Joanne E Martin; Martin Koltzenburg; Linda Greensmith; Patrick M Nolan; Elizabeth M C Fisher
Journal:  Dis Model Mech       Date:  2009-05-26       Impact factor: 5.758

4.  Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d.

Authors:  Emily L Spaulding; James N Sleigh; Kathryn H Morelli; Martin J Pinter; Robert W Burgess; Kevin L Seburn
Journal:  J Neurosci       Date:  2016-03-16       Impact factor: 6.167

5.  Functional substitution of a eukaryotic glycyl-tRNA synthetase with an evolutionarily unrelated bacterial cognate enzyme.

Authors:  Chin-I Chien; Yu-Wei Chen; Yi-Hua Wu; Chih-Yao Chang; Tzu-Ling Wang; Chien-Chia Wang
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.